Accretion Pharmaceuticals IPO Sales, Profits, and other Financial Details - What you should know about the Accretion Pharmaceuticals IPO

Accretion Pharmaceuticals IPO Review - Issue Date, Price, GMP, Subscription, Allotment, Lot Size, and Details

IPO Details IPO GMP IPO Subscription Reviews About Company IPO Timeline KPI Financial Information Peer Comparison Allotment

Financial Information of Accretion Pharmaceuticals Limited IPO
The Revenues from operations for the period ended on Dec 31, 2024, Fiscals ended 2024, 2023 and 2022 were ₹ 3,574.93 Lakh, ₹ 3,393.86 Lakh, ₹ 2,953.15 Lakh and ₹ 2,258.42 Lakh respectively. The EBITDA for the period ended on Dec 31, 2024, Fiscals ended 2024, 2023 and 2022 were ₹ 882.45 Lakh, ₹ 776.28 Lakh, ₹ 213.85 Lakh, and ₹ 193.10 Lakh, respectively. The Profit after Tax for the period ended on Dec 31, 2024, Fiscals ended 2024, 2023 and 2022 were ₹ 523.55 Lakh, ₹ 387.53 Lakh, ₹ 10.39 Lakh, and ₹ 7.90 Lakh respectively. This indicates a steady growth in financial performance.

Accretion Pharmaceuticals Limited Financial Information (Restated Consolidated)

Amount in (₹ in Lakh)

Period Ended	Dec 31, 2024	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022
Reserve of Surplus	541.31	134.76	-	-
Total Assets	3,998.83	2,704.61	2,059.97	1,774.12
Total Borrowings	1,378.98	1,348.22	846.58	760.75
Fixed Assets	614.09	527.27	601.23	583.59
Cash	18.64	9.16	3.64	37.45
Net Borrowing	1,360.34	1,339.06	842.94	723.30
Revenue	3,574.93	3,393.86	2,953.15	2,258.42
EBITDA	882.45	776.28	213.85	193.10
PAT	523.55	387.53	10.39	7.90
EPS	8.74	9.69	0.26	0.20

Note 1:- RoE, ROCE & RoNW calculation in KPI is based on 31st Mar, 2024 Data, given in RHP.
Note 2:- Pre EPS and Post EPS calculation in KPI is based (Profit/Loss for the Year) on 31st Mar, 2024 Data, given in RHP.
Note 3:- RoNW calculation in KPI is based on 31st Mar, 2024 Data, given in RHP.
Note 4:- Price to Book Value calculation in KPI is based on 31st Dec, 2024 Data, given in RHP.